(Reuters) – People who got Johnson & Johnson Inc’s COVID-19 vaccine as a first shot had a stronger immune response
Continue reading »
Home »
NIH expands clinical trials to test convalescent plasma against COVID-19
Two randomized, placebo-controlled clinical trials funded by the National Institutes of Health (NIH) are expanding enrollment to further evaluate convalescent
Continue reading »
NIH begins testing Ebola treatment in early-stage trial
A first-in-human trial evaluating an experimental treatment for Ebola virus disease has begun at the National Institutes of Health (NIH)
Continue reading »